Form 4: Clene Inc. Director Acquires Stock Options

Clene Inc. director Arjun Desai was granted stock options for 3,280 shares of common stock at an exercise price of $4.40 per share.

Summary

• Arjun Desai, a director at Clene Inc., was granted stock options on December 6, 2024.
• The options are for 3,280 shares of Clene Inc. common stock.
• The exercise price for these options is $4.40 per share.
• The options vest immediately upon grant.
• The options expire on December 5, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• Immediate vesting of the options may incentivize the director to contribute to the company's success.

Industry Context

Stock option grants to directors are a common practice in publicly traded companies to incentivize performance and align interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for directors in publicly listed companies.
• The vesting schedule of immediately upon grant is not uncommon, but can vary by company and role.
• The exercise price of $4.40 per share is specific to Clene Inc. and would need to be compared to other companies in the same sector to determine if it is standard.

Stakeholder Impact

• The stock option grant may be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

stock options, insider trading, beneficial ownership, equity, Clene Inc., director, Arjun Desai